Prevention of Hepatocellular Carcinoma
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 9 (2) , 329-346
- https://doi.org/10.1016/j.cld.2004.12.008
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Interferon-α for HBeAg-positive chronic hepatitis BJournal of Hepatology, 2003
- 220 Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B: a prospective double-blind placebo-controlled clinical trialHepatology, 2003
- Management of Chronic Hepatitis B: An OverviewSeminars in Liver Disease, 2002
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approachPublished by Elsevier ,2001
- The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2001
- Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type BGut, 2000
- Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfaHepatology, 1997
- Hepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective StudyHepatology, 1997
- Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosisJournal of Hepatology, 1996
- Hepatocellular carcinomaDigestive Diseases and Sciences, 1991